Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/13/1998 | EP0591492B1 A pharmaceutical composition containing a defined lipid system |
05/13/1998 | EP0525002B1 2[5H]-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca 2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS |
05/13/1998 | CN1181783A Medical composition |
05/13/1998 | CN1181755A THF-containing sulfonamide inhibitors of aspartyl protease |
05/13/1998 | CN1181753A Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
05/13/1998 | CN1181752A Process for the prepn. of 2, 2' -bipyrrolyl-pyrromethene (prodigiosins) derivatives |
05/13/1998 | CN1181706A Arteriovenous and venous graft treatments: methods and compsns. |
05/13/1998 | CN1181703A Controlled release of miotic and mydriatic drugs in the anterior chamber |
05/13/1998 | CN1181702A Neovascularization inhibitor |
05/13/1998 | CN1181701A Pharmaceutical compsn. containing N-chlorophenylcar-bamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses andcancers |
05/13/1998 | CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
05/13/1998 | CN1181699A Aminotetralin derivative for the therapy of cardiovascular diseases |
05/13/1998 | CN1181698A Method for topical treatment of scar tissue and related tissue reaction to trauma |
05/13/1998 | CN1181422A Gene transfer carrier structured by polypeptide in conjunction with growth factor receptor |
05/13/1998 | CN1181387A Novel polyhydro derivatives of tylosine and process for their preparation |
05/13/1998 | CN1181382A Vinylpyrrolidinon cephalosporin derivatives |
05/13/1998 | CN1181381A Synthetizing and application of laevo-rotation ofloxacin analogue |
05/13/1998 | CN1181372A Sesquiterpene compound and its use |
05/13/1998 | CN1181264A Zaohuang paste and treating burns and its prepn. |
05/13/1998 | CN1181263A Auxiliary tablet and aspirin in application for treating mental retardation |
05/13/1998 | CN1181262A Preparation for treating burns and empyrosis and its preparing process |
05/13/1998 | CN1181246A Fumigation-washing medicine for treating haemorrhoids and its prepn. method |
05/13/1998 | CN1181239A Method for preparing film forming sterilizing agent |
05/13/1998 | CN1181238A preparations |
05/13/1998 | CN1038328C Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their prepn. |
05/13/1998 | CN1038327C Process for prepn. of cephalosporin derivative |
05/13/1998 | CN1038326C 5 -aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient |
05/13/1998 | CN1038304C Method for prepn. of growth inhibiting compsn. |
05/13/1998 | CN1038303C Process for preparing oral haemorrhods drug |
05/12/1998 | US5750784 Method for effecting vasodilation with (1,5-inter) aryl prostaglandin derivatives |
05/12/1998 | US5750783 Benzyloxy-substituted phenylglycinolamides |
05/12/1998 | US5750744 Enzyme inhibitors |
05/12/1998 | US5750735 Chemical intermediates for antibiotics |
05/12/1998 | US5750724 Indolealkyl derivatives of benzodioxanmethylamine |
05/12/1998 | US5750720 Alpha-adrenoreceptors and central nervous systems |
05/12/1998 | US5750712 Diabetic therapy |
05/12/1998 | US5750709 Method and apparatus for isolating therapeutic compositions from source materials |
05/12/1998 | US5750708 Pyridine compounds intermediates processes compositions and methods |
05/12/1998 | US5750706 Azepanes and their ring homologues having protein kinase inhibiting activity |
05/12/1998 | US5750703 Purity; antihistamines; antiallergens; bronchodilators |
05/12/1998 | US5750702 Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands |
05/12/1998 | US5750701 Heterocyclic ethanolamine derivatives with β-adrenoreceptor agonistic activity |
05/12/1998 | US5750695 Antiparasitic paraherquamides |
05/12/1998 | US5750693 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
05/12/1998 | US5750688 Reacting an halogenated amine with an oxybenzoic ester; then a 2-(oxyphenyl-)benzothiophene compound |
05/12/1998 | US5750687 Angiotensin converting enzyme inhibitors, neutral endopeptidase inhibitors |
05/12/1998 | US5750673 Nucleosides with 2'-O-modifications |
05/12/1998 | US5750669 Nuclease-stable antiviral agents which can suppress synthesis of antigens and gene expression of proteins |
05/12/1998 | US5750665 Preparation of glucosaminyl muramic acid derivatives |
05/12/1998 | US5750664 Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
05/12/1998 | US5750579 Solution of disinfectant, alcohol, thickener |
05/12/1998 | US5750578 Viricides |
05/12/1998 | US5750576 Triphenylethylenes for the prevention and treatment of osteoporosis |
05/12/1998 | US5750575 Antiinflammatory agents; immunosuppressants; cytotoxic agents; microbiocides; fungicides |
05/12/1998 | US5750573 Guanylhydrazones and their use to treat inflammatory conditions |
05/12/1998 | US5750572 Anticoagulants |
05/12/1998 | US5750571 Methods and therapeutic compositions for treating cystic fibrosis |
05/12/1998 | US5750570 Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
05/12/1998 | US5750569 Lowering plasma lipids |
05/12/1998 | US5750567 Farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
05/12/1998 | US5750566 Synthetic excitatory amino acids |
05/12/1998 | US5750564 Anti-oxidant esters of non-steroidal anti-inflammatory agents |
05/12/1998 | US5750563 Preparation for epidermis |
05/12/1998 | US5750562 Antitumor agents; water soluble; side effect reduction |
05/12/1998 | US5750561 Compositions containing taxane derivatives |
05/12/1998 | US5750560 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives |
05/12/1998 | US5750559 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
05/12/1998 | US5750557 Method and pharmaceutical formulation for treating benign prostatic hyperplasia |
05/12/1998 | US5750556 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano- 2,3-E!indol-8-ones and derivatives |
05/12/1998 | US5750555 Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino acid as PKC inhibitors |
05/12/1998 | US5750554 Compounds for treatment of anxiety, depression, antisecretory agents, hypotensive agents and treatment of eating problems |
05/12/1998 | US5750553 Antiandrogenic agents |
05/12/1998 | US5750552 Antiulcer agents |
05/12/1998 | US5750551 Angiotensin inhibitors, benzimidazole derivatives |
05/12/1998 | US5750546 2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof |
05/12/1998 | US5750543 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
05/12/1998 | US5750542 Cholinesterase inhibitors, memory enhancers |
05/12/1998 | US5750541 Method of treating schizophrenia |
05/12/1998 | US5750539 Antiasthmatics |
05/12/1998 | US5750538 1,2,5-thiadiazol-4-yl-1-azabicyclic derivatives |
05/12/1998 | US5750537 Use of 5HT3 antagonist to treat impotence |
05/12/1998 | US5750535 Bactericides |
05/12/1998 | US5750534 Administering esterase hydrolyzable prodrug for sustained in-vivo release of nalbuphine; drug delivery |
05/12/1998 | US5750533 Plants, animals |
05/12/1998 | US5750531 Pyrimidine derivatives and processes for the preparation thereof |
05/12/1998 | US5750530 Pharmaceutical diketopiperazine compounds |
05/12/1998 | US5750529 Apoptosis regulating compostion |
05/12/1998 | US5750528 Evaluting compounds for diseases involving neurotransmitter deficiencies, traumatic brain injury or depressive phase of bipolar disorder by comparing the difference in m-current amplitude between a known blocker and a candidate compound |
05/12/1998 | US5750527 Viricides |
05/12/1998 | US5750526 Pyrido 1,2,3-DE!quinoxaline derivatives, process for their production and their use in pharmaceutical agents |
05/12/1998 | US5750525 Antagonists of excitatory amino acids used for treatment of neurological and psychiatric disorders |
05/12/1998 | US5750524 Administering an sulfamide substituted indan derivative |
05/12/1998 | US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
05/12/1998 | US5750520 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
05/12/1998 | US5750519 Administering dopamine antagonist and prolactin stimulator |
05/12/1998 | US5750518 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation and rheumatoid arthritis |
05/12/1998 | US5750515 Cancer metastasis inhibitor |
05/12/1998 | US5750514 Method for controlling ectoparasites |
05/12/1998 | US5750512 For treatment of parkinson's and alzheimer's disease or mental depression |
05/12/1998 | US5750507 Method for preventing or treating arrhythmia |